133 related articles for article (PubMed ID: 8218732)
1. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
[TBL] [Abstract][Full Text] [Related]
2. In vivo characteristics of low molecular weight copolymers composed of L-lactic acid and various DL-hydroxy acids as biodegradable carriers for drug delivery systems.
Fukuzaki H; Yoshida M; Asano M; Kumakura M; Mashimo T; Yuasa H; Imai K; Yamanaka H
Biomaterials; 1990 Aug; 11(6):441-6. PubMed ID: 2207236
[TBL] [Abstract][Full Text] [Related]
3. Sustained drug release characteristics of biodegradable composite poly(d,l)lactic acid-poly(l)lactic acid microcapsules containing ciprofloxacin.
Yu WP; Wong JP; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):39-55. PubMed ID: 10676576
[TBL] [Abstract][Full Text] [Related]
4. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid).
Omelczuk MO; McGinity JW
Pharm Res; 1992 Jan; 9(1):26-32. PubMed ID: 1589405
[TBL] [Abstract][Full Text] [Related]
5. In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with controlled release of LH-RH agonist.
Asano M; Fukuzaki H; Yoshida M; Kumakura M; Mashimo T; Yuasa H; Imai K; Yamanaka H
Biomaterials; 1989 Oct; 10(8):569-73. PubMed ID: 2513891
[TBL] [Abstract][Full Text] [Related]
6. [Intravitreal drug delivery by microspheres of biodegradable polymers].
Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
[TBL] [Abstract][Full Text] [Related]
7. Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
Asmus LR; Kaufmann B; Melander L; Weiss T; Schwach G; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Aug; 81(3):591-9. PubMed ID: 22561956
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of poly-D,L-lactic acid containing bleomycin.
Nakamura K; Natsugoe S; Kumanohoso T; Aikou T; Shinkawa T; Yamada K; Fukuzaki H
Anticancer Drugs; 1995 Jun; 6(3):483-7. PubMed ID: 7545481
[TBL] [Abstract][Full Text] [Related]
9. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
[TBL] [Abstract][Full Text] [Related]
10. Controlled cisplatin delivery system using poly(D,L-lactic acid).
Ike O; Shimizu Y; Wada R; Hyon SH; Ikada Y
Biomaterials; 1992; 13(4):230-4. PubMed ID: 1520828
[TBL] [Abstract][Full Text] [Related]
11. Transmucosal delivery systems for calcitonin: a review.
Torres-Lugo M; Peppas NA
Biomaterials; 2000 Jun; 21(12):1191-6. PubMed ID: 10811300
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid).
Andreopoulos AG
J Biomater Appl; 1995 Oct; 10(2):163-70. PubMed ID: 8618209
[TBL] [Abstract][Full Text] [Related]
13. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
14. In vitro release of new quinolones from biodegradable systems: a comparative study.
Andreopoulos AG; Korakis T; Dounis E; Anastasiadis A; Tzivelekis P; Kanellakopoulou K
J Biomater Appl; 1996 Apr; 10(4):338-47. PubMed ID: 8859405
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of insulin from plasma-irradiated sandwitch device using poly-DL-lactic acid.
Yamakawa I; Watanabe S; Matsuno Y; Kuzuya M
Biol Pharm Bull; 1993 Feb; 16(2):182-7. PubMed ID: 8364454
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable polymers for ocular drug delivery.
Kimura H; Ogura Y
Ophthalmologica; 2001; 215(3):143-55. PubMed ID: 11340382
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of cisplatin incorporated into biodegradable poly-d, l-lactic acid.
Natsugoe S; Kumanohoso T; Tokuda K; Shimada M; Mueller J; Nakamura K; Yamada K; Fukuzaki H; Aikou T
Anticancer Res; 1997; 17(3C):1957-60. PubMed ID: 9216651
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable hollow fibres for the controlled release of drugs.
Schakenraad JM; Oosterbaan JA; Nieuwenhuis P; Molenaar I; Olijslager J; Potman W; Eenink MJ; Feijen J
Biomaterials; 1988 Jan; 9(1):116-20. PubMed ID: 3126841
[TBL] [Abstract][Full Text] [Related]
20. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.
Pitt CG; Gratzl MM; Jeffcoat AR; Zweidinger R; Schindler A
J Pharm Sci; 1979 Dec; 68(12):1534-8. PubMed ID: 529046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
